A previous study reported a four-month-old infant with compound heterozygous Hb O-Arab and β0-thalassemia variant (HBB: c.92 + 1G>A), presenting severe manifestations, including neonatal hemolytic anemia and an enlarged spleen (Kalai et al., 2024). This evidence concerns the gene GSTM1 and thalassemia.